CA
AMPH icon

Commerzbank Aktiengesellschaft’s Amphastar Pharmaceuticals AMPH Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-26,182
Closed -$497K – 975
2016
Q3 		$497K Buy
+26,182
New +$475K 0.01% 572

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commerzbank Aktiengesellschaft's AMPH Position: Q4 2016 in Review

Commerzbank Aktiengesellschaft sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2016, closing a stake of 26,182 shares — an estimated $497K sold.

Commerzbank Aktiengesellschaft first reported a position in AMPH in Q3 2016 and held it in 1 quarter. The position peaked at $497K in Q3 2016. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

  • Commerzbank Aktiengesellschaft reported no remaining Amphastar Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 26,182 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $497K.
  • Commerzbank Aktiengesellschaft first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's Amphastar Pharmaceuticals position peaked at $497K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2016, filed 7 Feb 2017.